LegoChem Biosciences Inc (141080) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.21x

LegoChem Biosciences Inc (141080) has a Cash Flow Reinvestment Rate of 0.21x as of December 2024, reinvesting ₩16.78 Billion (capex ₩5.70 Billion plus investments ₩-11.08 Billion) from operating cash flow of ₩78.48 Billion. Check 141080 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.21x

(Capex + Investments) / Operating CF

Total Reinvested

₩16.78 Billion

Capex + Investments

Operating Cash Flow

₩78.48 Billion

KRW

Capital Expenditures

₩5.70 Billion

KRW

LegoChem Biosciences Inc Cash Flow Reinvestment Rate (2019–2024)

Historical reinvestment intensity for LegoChem Biosciences Inc across 2 annual periods. Explore LegoChem Biosciences Inc (141080) investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for LegoChem Biosciences Inc (2019–2024)

Year-by-year capital reinvestment analysis for LegoChem Biosciences Inc. For live market cap and broader valuation context, see LegoChem Biosciences Inc (141080) total market value.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2024	5.90x	₩463.07 Billion	₩78.48 Billion	₩5.70 Billion	▲ +286.3%
2019	1.53x	₩36.83 Billion	₩24.11 Billion	₩3.37 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow